How a large cap pharma in the Direct Oral Anticoagulant Space (DOAC) space updated its promotional tactics to regain lost SoV.
March 20, 2024Case studiesmarket intelligence,pharma marketing,Share Of Voice,DOAC,Direct Oral Anticoagulants
The challenge: Stimulating conversation around your brand when your competitors…
How a mid-size pharma in the US asthma and COPD space edged out two new competitive threats by differentiating its education approaches.
March 20, 2024Case studiesCOPD,Asthma,medical education
The challenge: How to prepare when two new competitors enter your space Α…
How a pharma in the multiple myeloma space gained access to leading KOLs insights and used them in its asset development process.
March 20, 2024Case studiesMultiple Myeloma,hematology,multiple myeloma treatments,multiple myeloma KOLs
The Challenge: Understanding how KOLs define the treatment evolution and the…
How we helped a mid-size pharma prepare its sales (SF) and medical teams (MSL) for a competitor's new launch in the migraine prevention space.
March 20, 2024Case studiescompetitive intelligence,migraine,case study,our work,Sales Strategy,Migraine Treatment
The Challenge: Knowing your competitor's new asset market entry timelines.…
How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts.
March 20, 2024Case studiescase study,our work,drug development,pharma marketing,prostate cancer,clinical development,patient needs
The Challenge: Mapping prostate cancer stage and identifying key stakeholders…
A major pharma in the COPD / Asthma space strengthened its market position due to competitive intelligence obtained through conference coverage.
March 20, 2024Case studiescompetitive intelligence,case study,our work,COPD,Asthma,Conference Insights
The Challenge: Gathering competitive intelligence at conferences Α major…
How we helped a major pharma identify and monitor existing and new Gx EU competitors and settle specific court actions with few of them.
March 20, 2024pharma,Case studies,generics,case study,our work,pharma manufacturing,market intelligencepharma launch
The challenge: Identifying and monitoring current and potential competitors and…
How we helped a specialty respiratory company understand the "trends" of severe asthma and COPD assets and position itself strategically.
March 20, 2024Case studiesRespiratory,case study,our work,COPD,Asthma,KOLengagement,ERS,monoclonal antibody
The Challenge: Staying updated with emerging trends in the respiratory market…
How a large pharma in the EU oncology space gained and used competitive intelligence to craft a defense against threats from generics.
March 20, 2024Case studiesOncology,competitive intelligence,generics,case study,our work,pharma manufacturing,EUpharma,breast cancer,generic cancer drugs,EU generics
The Challenge: Gaining Competitive Intelligence on upcoming generics…
How we helped two pharma companies assess their own and their competitors' social media during ESMO 2023 and ASCO 2023.
March 20, 2024Case studiesOncology,clinical trials,case study,our work,hematology,social media monitoring,KOLs,ESMO 2023,ASCO 2023
The Challenge: How to maximize the benefits of social media monitoring during…
How our benchmarking analysis contributed to a Hemato-Oncology company's sales and pricing strategy for specific agents.
March 20, 2024Case studiesOncology,competitive intelligence,case study,our work,hematology,Pricing Strategy
The Challenge: Competitive benchmarking, including sales force and market…
How a hematology brand utilized competitor sales force research to defend itself against a competitor entrant in Spain.
March 4, 2024Case studiescompetitive intelligence,case study,our work,hematology,Sales Strategy,pharma launch,competitor analysis,drug launch
The Challenge: How to react to a new entrant threat A hematology brand team of…


